Characteristics | Value |
---|---|
Demographics | |
Age, years, mean (range) | 69.0 (42.0 to 94.0) |
Sex, n (%) | |
Male | 27 (54.0) |
Female | 23 (46.0) |
Ethnicity, n (%) | |
White or Caucasian | 42 (84.0) |
Hispanic or Latino | 2 (4.0) |
Other or unspecified | 6 (12.0) |
Most frequent diagnoses, n (%)* | |
Hyperlipidemia | 38 (76.0) |
Hypertension | 38 (76.0) |
Type 2 diabetes mellitus | 23 (46.0) |
Hypothyroidism | 16 (32.0) |
Vitamin D deficiency | 16 (32.0) |
Allergic rhinitis | 11 (22.0) |
Anxiety | 10 (20.0) |
Gastroesophageal reflux disorder | 10 (20.0) |
Major depressive disorder | 8 (16.0) |
Insomnia | 7 (14.0) |
Medications | |
Number, mean (± SD)† | |
Total medications | 12.1 (± 4.6) |
Chronic medications | 10.4 (± 4.3) |
Medication risk mitigation–associated factors | |
Cognitive burden risk score | 2.0 (± 1.7) |
Falls risk score | 5.5 (± 4.0) |
Number of PIMs | 1.4 (± 1.2) |
Creatinine clearance (mL/min) | 66.2 (± 20.8) |
Heart rhythm risk score | 3.6 (± 3.6) |
Most frequently prescribed, n (%)‡ | |
Aspirin | 25 (50.0) |
Vitamin D | 24 (48.0) |
Atorvastatin | 23 (46.0) |
Levothyroxine | 17 (34.0) |
Omega-3 fatty acids | 14 (28.0) |
Amlodipine | 13 (26.0) |
Esomeprazole | 11 (22.0) |
Clopidogrel | 8 (16.0) |
Metoprolol succinate | 8 (16.0) |
Omeprazole | 8 (16.0) |
↵* As reported in the patient’s chart. Percentage out of total patients included.
↵† As determined by the pharmacist’s medication reconciliation process.
↵‡ As determined by the pharmacist’s medication reconciliation process. Percentage out of total patients included.
Abbreviations: PIM, potentially inappropriate medication; SD, standard deviation.